Press Releases

After announcing on October 17, 2017 that Neothetics, Inc. (NASDAQ:NEOT) and Evofem Biosciences, Inc. have entered into a definitive agreement under which privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction, Neothetics, Inc. filed on November 15, 2017 a Form S-4 to the SEC. On December 7, 2017, Neothetics filed an amednment on FormS-4/A. Click here to view this filing.